SBIR Phase I: COVID-19-impermeable high-performance porous coatings for respiratory personal protective equipment
SBIR 第一阶段:用于呼吸个人防护设备的 COVID-19 不渗透高性能多孔涂层
基本信息
- 批准号:2034453
- 负责人:
- 金额:$ 25.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project encompasses development new coatings for face masks and filtration pieces for N95-grade respirators. The outer layer will repel the viral particles while the inner layer will adsorb moisture, making the mask comfortable for wear and assisting with social distancing compliance during the COVID-19 pandemic. The coatings are efficient in their function, provide reliable protection, and are durable. This technology is also highly promising for applications in other types of personal protective equipment such as gowns, drapes, medical aprons, as well as coatings on disposable medical devices. Apart from the medical sector, this platform has potential advantages for other goods, pharmaceutical formulations, and personal care products. This SBIR Phase I project proposes to develop innovative formulations for deposition of high-performance superhydrophobic and superhydrophilic coatings on textile surfaces for personal protective equipment. The technical innovation is fabrication of novel dendritic polymer particles with extraordinary high surface area and unusually strong adhesivity. The soft dendritic colloids are formed when a polymer solution is injected into turbulently sheared anti-solvent medium. Random stretching of the polymer solution droplets by the turbulent anti-solvent flow causes the polymer to precipitate in the form of soft dendritic structures. The critical technical hurdle is scaling manufacturing of large volumes of soft dendritic particles with fractal morphology. Technical objectives are: 1) develop an efficient liquid-based process for soft dendritic colloids fabrication on a bench scale; and 2) characterize textiles coated with the new formulations using a series of morphological, filtration efficiency, and breathability tests.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这项小型企业创新研究(SBIR)项目的更广泛的影响/商业潜力涵盖了开发面罩的新涂料和N95级呼吸器的过滤材料。外层将排斥病毒颗粒,而内层将吸附水分,使面罩舒适地磨损,并协助在COVID-19大流行期间的社交距离合规性。涂料的功能有效,提供可靠的保护,并且耐用。对于在其他类型的个人防护设备(例如礼服,窗帘,医疗围裙)以及一次性医疗设备上的涂料等其他类型的个人防护设备中,该技术也非常有前途。除了医疗部门,该平台还具有其他商品,药品配方和个人护理产品的潜在优势。这个SBIR I期项目提议开发创新的配方,用于在纺织品表面上为个人保护设备的高性能超疏水和超养分涂料的沉积。技术创新是制造具有非凡高表面积和异常强的粘附性的新型树突聚合物颗粒。当将聚合物溶液注入湍流剪切的抗溶剂溶质培养基中时,会形成软树突胶体。通过湍流抗可溶性流对聚合物溶液的随机拉伸导致聚合物以软树突结构的形式沉淀。关键的技术障碍是扩展具有分形形态的大量软树突颗粒的生产。技术目标是:1)开发一种有效的基于液体的过程,用于在基准尺度上制造软性树突状胶体制造; 2)用一系列形态学,过滤效率和透气性测试来表征覆盖新配方的纺织品。该奖项反映了NSF的法定任务,并被认为是值得通过基金会的知识分子和更广泛影响的评估评估标准来通过评估来支持的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anka Veleva其他文献
Anka Veleva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anka Veleva', 18)}}的其他基金
SBIR Phase II: Lignin-Based Formulations for Efficient and Sustainable Control of Plant Pathogens
SBIR 第二阶段:用于有效和可持续控制植物病原体的木质素配方
- 批准号:
1950915 - 财政年份:2020
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase I: Lignin-Based Formulations for Efficient and Sustainable Control of Plant Pathogens
SBIR 第一阶段:基于木质素的制剂,用于有效和可持续地控制植物病原体
- 批准号:
1746692 - 财政年份:2018
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
STTR Phase I: Novel Molecularly Targeted Tracer for Specific and Sensitive Imaging of Cancer
STTR 第一阶段:用于癌症特异性和灵敏成像的新型分子靶向示踪剂
- 批准号:
1321424 - 财政年份:2013
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
相似国自然基金
高层钢结构建模-优化-深化的跨阶段智能设计方法
- 批准号:52308142
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
游戏化mHealth干预模式下精神障碍出院患者自杀风险管理策略的实施科学研究——基于多阶段优化策略
- 批准号:72374095
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
非洲爪蟾IV型干扰素IFN-upsilon在不同发育阶段的抗病毒功能研究
- 批准号:32303043
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
壳斗科植物传播前阶段种子捕食的地理格局及其驱动机制
- 批准号:32371612
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
计及海量多元逆变资源下垂参数动态优化的配电网多阶段协调运行研究
- 批准号:52307091
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
SBIR Phase II: Design and production of a next generation vaccine to prevent COVID
SBIR 第二阶段:设计和生产下一代预防新冠病毒的疫苗
- 批准号:
2313338 - 财政年份:2024
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Facilitating Early Childhood Teacher and Family Engagement During COVID-19
SBIR 第二阶段:在 COVID-19 期间促进幼儿教师和家庭的参与
- 批准号:
2151349 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Machine Learning for Rapid Automated Viral Infectivity Assays (COVID-19)
SBIR 第二阶段:用于快速自动化病毒感染性检测的机器学习 (COVID-19)
- 批准号:
2136850 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase I: A platform for simulating the combined effect of human behavior and environment on airborne infectious spread (COVID-19)
SBIR 第一阶段:模拟人类行为和环境对空气传播传染病(COVID-19)综合影响的平台
- 批准号:
2151672 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase II: Microbial Discovery and Biosynthesis of Targeted Protease Inhibitors (COVID-19)
SBIR 第二阶段:微生物发现和靶向蛋白酶抑制剂(COVID-19)的生物合成
- 批准号:
2213051 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement